The VA Just Started a Phase 3 Psilocybin Trial. The Control Group Gets Psilocybin Too
The VA began enrolling 240 veterans in a phase 3 psilocybin trial on August 3. There is no placebo arm, and that changes what the study can prove.
Read More
Psilocybin Sessions for PTSD Are Mostly Silent. The Argument About What to Call Them Is Not
A new analysis found psilocybin dosing sessions for PTSD are silent 78 percent of the time. Why the authors want the name changed, and who benefits if it is.
Read More
Cluster Headaches Have New Trial Data. Ketamine Clinics Should Be Paying Attention
Two 2024 randomized trials cut cluster headache attacks with pulse dose psilocybin. Where ketamine sits, why these patients overlap with yours, and the access gap.
Read More
Psychedelic Trials Are Going Intravenous. Ketamine Clinics Already Have That Room
A new trial of intravenous psilocin points to where psychedelic delivery is heading. Ketamine clinics already have the infusion rooms and titration skills it needs.
Read More
Why Some Psychedelic Sessions Turn Frightening. A New Brain Study Offers a Clue
Most people who take a psychedelic under clinical supervision come through the session well. Some do not. A 2026 Stanford study in the Proceedings of the National Academy of Sciences offers a partial explanation for that difference. The clue sits in an unexpected place, namely the direction brain signals travel. Do you work in the […]
Read More
Nine of 12 Veterans Reached PTSD Remission After Psilocybin Therapy in Small Study
A small clinical trial found striking improvements among veterans with severe post traumatic stress disorder that had resisted standard care. Nine of 12 participants no longer met PTSD criteria one month after psilocybin assisted therapy. The result offers an important signal, but the study cannot prove that the treatment caused the improvement. Looking for treatment? Find Spravato clinics […]
Read More
Minnesota Moves Closer to Expanding Access to Psilocybin Therapy
Minnesota is moving closer to creating a regulated psilocybin therapy program, although legal access will not begin this year.
Read More
Connecticut Opens Psychedelic Therapy Pilot To More Adults As Demand Grows
Connecticut is widening access to a medical psychedelic therapy program at a moment when public interest has clearly outpaced availability.
Read More
The Mushroom That Makes People See Tiny People Is Not Acting Like Psilocybin
The mushroom, Lanmaoa asiatica, has been linked to visions of miniature people. The story sounds folkloric, but the science behind it isn't.
Read More
Nearly 5 Million Veterans Have Tried Psychedelics, RAND Study Finds
Psychedelics are no longer a fringe topic among veterans. They are part of the lived experience of millions of those who serve in the military.
Read More